Charles Craik

Charles Craik is a Professor in the Department of Pharmaceutical Chemistry at the University of California San Francisco (UCSF), where he leads a research group focused on the chemical biology of proteolytic enzymes and protein degradation pathways. His work has broad implications for understanding and treating infectious diseases, cancer, and neurodegenerative disorders.

His research interests include:

• Chemical biology of proteases and protein degradation
• Structural and mechanistic studies of enzymes
• Development of novel technologies for biophysical characterization
• Global substrate profiling and antibody engineering
• Noninvasive imaging for disease monitoring
• Therapeutic intervention strategies

The recent publications from the Craik lab demonstrate a strong trend in structural biology, enzyme mechanism, infectious disease (especially coronavirus and fungal pathogens), cancer (particularly KRAS and tau-related pathways), and neurodegeneration. His work often involves interdisciplinary collaboration and high-impact methodologies such as cryo-EM, X-ray crystallography, and activity-based profiling.

Scientific awards and honors are not explicitly mentioned in the provided text.

Dr. Craik mentors numerous students and postdoctoral researchers, as evidenced by extensive co-authorship on publications. His lab receives significant research funding, though specific grants are not detailed. He is actively involved in collaborative research across UCSF and with external institutions.

His laboratory develops and applies advanced technologies for studying challenging proteins, including protease activity probes, antibody-drug conjugates, and imaging agents. The team frequently works on translating basic science discoveries into diagnostic and therapeutic applications.